(Q43777184)

English

Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis

scientific article published on 7 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

glucocorticoid resistance

1 reference

based on heuristic

inferred from title

author name string

L Gu

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

J Gao

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Q Li

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Y P Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C S Jia

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

R Y Fu

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Y Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Q K Liao

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Z Ma

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

7 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

2091-2096

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

21 January 2018

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticoid resistance in childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of glucocorticoid action and resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Anaplastic lymphoma kinase proteins in growth control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Upstream and downstream of mTOR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

An expanding role for mTOR in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

mTOR signalling in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2008.204

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43777184&oldid=2206252315"